| Literature DB >> 24586494 |
Mohammad Reza Aflatoonian1, Iraj Sharifi2, Maryam Hakimi Parizi2, Ali Reza Fekri2, Behnaz Aflatoonian3, Maryam Sharifi4, Ahmad Khosravi2, Ali Khamesipour5, Hamid Sharifi6.
Abstract
Opium addiction and cutaneous leishmaniasis (CL) are endemic in different parts of Iran, particularly in Bam, where a massive earthquake occurred. This study was designed to compare the incidence rate and severity of CL cases among opium addicted and non-addicted individuals in south-eastern Iran. This study was carried out as a prospective cohort by active house-to-house visits of 1,481 habitants in Bam. CL cases were confirmed by smear and identification of Leishmania species was performed using nested-PCR. The data was analyzed by χ(2) and t-tests, using SPSS software and also Kaplan-Meier survival curve and long-rank test in Stata 11.2 and P<0.05 was considered as significant. A total of 904 individuals consisting of 226 opium addicted and 678 non-addicted individuals were followed-up for a period of seven years. The two cohorts were similar in terms of age, sex and place of residency. A similar pattern of incidence was observed among the two cohort groups. In contrast, the severity of CL in terms of the number, duration and the size of the lesions in opium addicted individuals was significantly (P<0.001) higher than non-opium addicted individuals. In conclusion, the present findings indicate that there is no relationship between the incidence of CL and opium addiction.Entities:
Mesh:
Year: 2014 PMID: 24586494 PMCID: PMC3930687 DOI: 10.1371/journal.pone.0089043
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Study design.
Baseline characteristics of study participants.
| Characteristic | PopulationNumber (%) | Opium addictionNumber (%) | CutaneousleishmaniasisNumber (%) |
|
| 118(5.8) | 0(0) | 39(15.7) |
|
| 280(13.8) | 6(2.1) | 75(30.1) |
|
| 1379(68.1) | 185(13.4) | 117(47.0) |
|
| 249(12.3) | 57(22.9) | 18(7.2) |
|
| 2026(100.0) | 248(100.0) | 249(100.0) |
|
| 1025(50.6) | 231(93.1) | 108(43.4) |
|
| 1001(49.4) | 17(6.9) | 141(56.6) |
Age and sex distributions of opium addicted and non – addicted cohorts.
| Characteristic | Examinedpopulation | Addicted | Non – addicted |
|
| Number (%) | Number (%) | Number (%) |
|
| 231(35.9) | 70(34.8) | 161(36.4) |
|
| 225(35.0) | 72(35.8) | 153(34.6) |
|
| 187(29.1) | 59(29.3) | 128(29.0) |
|
| |||
|
| 618(96.1) | 193(96.0) | 425(96.2) |
|
| 25(3.9) | 8(4.0) | 17(3.8) |
*There was no significant difference among the opium addicted and non-addicted with respect to age or gender.
The incidence of cutaneous leishmaniasis cases in opium addicted and non – addicted cohorts by the year of contraction.
| Year | Opium addicted | Incidence No (%) | Opium non –addicted | Incidence No (%) |
|
| 201 | 1(0.5) | 442 | 3(0.7) |
|
| 200 | 3(1.5) | 439 | 7(1.6) |
|
| 197 | 11(5.6) | 432 | 22(5.1) |
|
| 186 | 9(4.8) | 410 | 19(4.6) |
|
| 177 | 7(3.9) | 391 | 14(3.6) |
|
| 170 | 4(2.3) | 377 | 12(3.2) |
|
| 166 | 3(1.8) | 365 | 9(2.5) |
|
| 1297 | 38(2.9) | 2860 | 86(3.0) |
*There was no significant difference between the incidence rates among the two cohorts.
The Severity of cutaneous leishmaniasis cases in opium addicted and non –addicted cohorts in terms of the number, duration and size of the lesions.
| Characteristics | Opium addictedNo (% ) | Opium non –addictedNo (% ) | |
|
| 1 | 22(57.9) | 63(73.3) |
| 2 | 8(21.0) | 13(15.1) | |
| ≥3 | 8(21.1) | 10(11.6) | |
|
| <3 | 13(34.2) | 45(52.3) |
| 3–6 | 11(28.9) | 24(27.9) | |
| 7–9 | 9(23.7) | 13(15.1) | |
| >9 | 5(13.2) | 4(4.7) | |
|
| <1 | 10(26.3) | 33(38.4) |
| 1–3 | 12(31.6) | 39(45.3) | |
| 4–5 | 9(23.7) | 11(12.8) | |
| >5 | 7(18.4) | 3(3.5) | |
*There was a significant difference between opium addicted and opium non –addicted cohorts (P<0.001).
Figure 2Location of the cutaneous leishmaniasis lesions in opium addicted and opium non – addicted cohorts.
Figure 3Kaplan-Meier survival estimates of cutaneous leishmaniasis in opium and opium non-addicted.
Figure 4Agarose gel electrophoresis prepared for amplification of variable minicircle fragments of Leishmania kDNA by the nested PCR. Lane 1, DNA size marker, 100 bp; lane 2, negative control (distilled water); lane 3, L.major (positive control, 560 bp); lane 4, L.tropica (positive control,750 bp); lanes 5–7, L.tropica isolates obtained from the cutaneous leishmaniasis cases among opium addicted and opium non-addicted cohorts.